LIFE - aTyr Pharma, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development30,06742,84633,09316,777
Selling General and Administrative17,07815,09413,1126,777
Non Recurring----
Total Operating Expenses47,14557,94046,20523,554
Operating Income or Loss-47,145-57,940-46,205-23,554
Income from Continuing Operations
Total Other Income/Expenses Net-1,06236-1,768-796
Earnings Before Interest and Taxes-47,145-57,940-46,205-23,554
Interest Expense----832
Income Before Tax-48,207-57,904-47,973-24,350
Income Tax Expense--49--
Minority Interest----
Net Income From Continuing Ops-48,207-57,855-47,973-24,350
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-48,207-57,855-47,973-24,350
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-48,207-57,855-47,988-24,766